|
CN102464654B
(zh)
|
2010-11-12 |
2016-01-13 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
|
CA2840095A1
(en)
|
2011-07-06 |
2013-01-10 |
Gilead Sciences, Inc. |
Compounds for the treatment of hiv
|
|
CN102863512B
(zh)
|
2011-07-07 |
2016-04-20 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
|
TW201443037A
(zh)
|
2013-01-09 |
2014-11-16 |
Gilead Sciences Inc |
治療用化合物
|
|
EP2943493B1
(en)
|
2013-01-09 |
2017-08-02 |
Gilead Sciences, Inc. |
Therapeutic compounds for the treatment of viral infections
|
|
US9220710B2
(en)
|
2013-01-09 |
2015-12-29 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
TWI694071B
(zh)
|
2013-03-01 |
2020-05-21 |
美商基利科學股份有限公司 |
治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物
|
|
WO2015130964A1
(en)
|
2014-02-28 |
2015-09-03 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
WO2015130966A1
(en)
|
2014-02-28 |
2015-09-03 |
Gilead Sciences, Inc. |
Antiviral agents
|
|
US9873680B2
(en)
|
2014-08-29 |
2018-01-23 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
CN107151223B
(zh)
|
2016-03-10 |
2020-03-31 |
中国医学科学院药物研究所 |
一类n-烷基吲哚类化合物在制备抗流感病毒药物中的用途
|
|
LT3347352T
(lt)
|
2016-08-19 |
2019-08-12 |
Gilead Sciences, Inc. |
Terapiniai junginiai, naudotini živ viruso infekcijos profilaktikai arba terapiniam gydymui
|
|
TW201906834A
(zh)
|
2017-05-02 |
2019-02-16 |
英商Viiv醫療保健英國(No.5)有限公司 |
人類免疫不全病毒複製之抑制劑
|
|
WO2019161017A1
(en)
|
2018-02-15 |
2019-08-22 |
Gilead Sciences, Inc. |
Pyridine derivatives and their use for treating hiv infection
|
|
KR102847339B1
(ko)
|
2018-02-16 |
2025-08-19 |
길리애드 사이언시즈, 인코포레이티드 |
레트로비리다에 바이러스 감염의 치료에 유용한 치료 화합물을 제조하기 위한 방법 및 중간체
|
|
WO2019198024A1
(en)
*
|
2018-04-11 |
2019-10-17 |
VIIV Healthcare UK (No.5) Limited |
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication
|
|
JP7361766B2
(ja)
*
|
2018-09-14 |
2023-10-16 |
ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド |
ヒト免疫不全ウイルス複製の阻害剤
|
|
WO2020084491A1
(en)
*
|
2018-10-24 |
2020-04-30 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|
|
MA53973A
(fr)
*
|
2018-10-24 |
2022-02-09 |
Viiv Healthcare Uk No 5 Ltd |
Inhibiteurs de la réplication du virus de l'immunodéficience humaine
|
|
PT3870575T
(pt)
*
|
2018-10-25 |
2023-05-12 |
Viiv Healthcare Uk No 5 Ltd |
Inibidores da replicação do vírus da imunodeficiência humana
|
|
JP2022506399A
(ja)
*
|
2018-11-05 |
2022-01-17 |
ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド |
ヒト免疫不全ウイルス複製の阻害剤
|
|
EP4038068A1
(en)
*
|
2019-10-01 |
2022-08-10 |
VIIV Healthcare UK (No.5) Limited |
N-substituted-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl derivatives as inhibitors of the human immunodeficiency virus replication
|
|
TW202128648A
(zh)
*
|
2019-10-04 |
2021-08-01 |
英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 |
人類免疫不全病毒複製之抑制劑
|
|
IL293566A
(en)
*
|
2019-12-09 |
2022-08-01 |
Viiv Healthcare Co |
Pharmaceutical preparations containing Cabotgravir
|
|
EP4135702B1
(en)
*
|
2020-04-15 |
2026-06-03 |
VIIV Healthcare UK (No.5) Limited |
Inhibitors of human immunodeficiency virus replication
|